Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension. / Hansen, Nadja Skadkær; Korsbæk, Johanne Juhl; Yri, Hanne Maria; Jensen, Rigmor Højland; Beier, Dagmar.

In: Cephalalgia, Vol. 44, No. 4, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hansen, NS, Korsbæk, JJ, Yri, HM, Jensen, RH & Beier, D 2024, 'Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension', Cephalalgia, vol. 44, no. 4. https://doi.org/10.1177/03331024241248210

APA

Hansen, N. S., Korsbæk, J. J., Yri, H. M., Jensen, R. H., & Beier, D. (2024). Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension. Cephalalgia, 44(4). https://doi.org/10.1177/03331024241248210

Vancouver

Hansen NS, Korsbæk JJ, Yri HM, Jensen RH, Beier D. Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension. Cephalalgia. 2024;44(4). https://doi.org/10.1177/03331024241248210

Author

Hansen, Nadja Skadkær ; Korsbæk, Johanne Juhl ; Yri, Hanne Maria ; Jensen, Rigmor Højland ; Beier, Dagmar. / Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension. In: Cephalalgia. 2024 ; Vol. 44, No. 4.

Bibtex

@article{0c2599c5852e4799abe8dcd79a5e92b2,
title = "Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension",
abstract = "Background: Headache burden is substantial in idiopathic intracranial hypertension. The classification of idiopathic intracranial hypertension headache by the International Classification of Headache Disorders (ICHD) is an important tool for research and clinical purposes. Methods: We phenotyped headaches and tested sensitivity and specificity of the ICHD-3 criteria for idiopathic intracranial hypertension headache in a prospective cohort of patients suspected of idiopathic intracranial hypertension at two tertiary headache centers. Results: Sensitivity was 93% and specificity was 100% of ICHD-3 criteria for idiopathic intracranial hypertension-related headache validated in idiopathic intracranial hypertension (n = 140) and patients in whom idiopathic intracranial hypertension was suspected but disproven (n = 103). The phenotype of new/worsened headaches related to idiopathic intracranial hypertension suspicion was equally migraine-like (p = 0.76) and tension-type-like (p = 0.08). Lumbar puncture opening pressure was higher (p < 0.0001) and pulsatile tinnitus more frequent (p < 0.0001) in idiopathic intracranial hypertension patients, but neither improved the applicability of the headache criteria, nor did papilledema. Conclusion: Headache phenotype is not distinct in idiopathic intracranial hypertension. ICHD-3 criteria for idiopathic intracranial hypertension headache are sensitive and specific, but simplicity can be improved without compromising accuracy. We propose that a new or worsened headache temporally related to active idiopathic intracranial hypertension is a sufficient criterion for idiopathic intracranial hypertension headache regardless of headache phenotype or accompanying symptoms, and that elements of idiopathic intracranial hypertension diagnostics (papilledema and opening pressure) be segregated from headache criteria. Trial Registration: ClinicalTrials.gov Identifier: NCT04032379",
keywords = "headache classification, Idiopathic intracranial hypertension, International Classification of Headache Disorders, intracranial pressure, migraine",
author = "Hansen, {Nadja Skadk{\ae}r} and Korsb{\ae}k, {Johanne Juhl} and Yri, {Hanne Maria} and Jensen, {Rigmor H{\o}jland} and Dagmar Beier",
note = "Publisher Copyright: {\textcopyright} International Headache Society 2024.",
year = "2024",
doi = "10.1177/03331024241248210",
language = "English",
volume = "44",
journal = "Cephalalgia",
issn = "0800-1952",
publisher = "SAGE Publications",
number = "4",

}

RIS

TY - JOUR

T1 - Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension

AU - Hansen, Nadja Skadkær

AU - Korsbæk, Johanne Juhl

AU - Yri, Hanne Maria

AU - Jensen, Rigmor Højland

AU - Beier, Dagmar

N1 - Publisher Copyright: © International Headache Society 2024.

PY - 2024

Y1 - 2024

N2 - Background: Headache burden is substantial in idiopathic intracranial hypertension. The classification of idiopathic intracranial hypertension headache by the International Classification of Headache Disorders (ICHD) is an important tool for research and clinical purposes. Methods: We phenotyped headaches and tested sensitivity and specificity of the ICHD-3 criteria for idiopathic intracranial hypertension headache in a prospective cohort of patients suspected of idiopathic intracranial hypertension at two tertiary headache centers. Results: Sensitivity was 93% and specificity was 100% of ICHD-3 criteria for idiopathic intracranial hypertension-related headache validated in idiopathic intracranial hypertension (n = 140) and patients in whom idiopathic intracranial hypertension was suspected but disproven (n = 103). The phenotype of new/worsened headaches related to idiopathic intracranial hypertension suspicion was equally migraine-like (p = 0.76) and tension-type-like (p = 0.08). Lumbar puncture opening pressure was higher (p < 0.0001) and pulsatile tinnitus more frequent (p < 0.0001) in idiopathic intracranial hypertension patients, but neither improved the applicability of the headache criteria, nor did papilledema. Conclusion: Headache phenotype is not distinct in idiopathic intracranial hypertension. ICHD-3 criteria for idiopathic intracranial hypertension headache are sensitive and specific, but simplicity can be improved without compromising accuracy. We propose that a new or worsened headache temporally related to active idiopathic intracranial hypertension is a sufficient criterion for idiopathic intracranial hypertension headache regardless of headache phenotype or accompanying symptoms, and that elements of idiopathic intracranial hypertension diagnostics (papilledema and opening pressure) be segregated from headache criteria. Trial Registration: ClinicalTrials.gov Identifier: NCT04032379

AB - Background: Headache burden is substantial in idiopathic intracranial hypertension. The classification of idiopathic intracranial hypertension headache by the International Classification of Headache Disorders (ICHD) is an important tool for research and clinical purposes. Methods: We phenotyped headaches and tested sensitivity and specificity of the ICHD-3 criteria for idiopathic intracranial hypertension headache in a prospective cohort of patients suspected of idiopathic intracranial hypertension at two tertiary headache centers. Results: Sensitivity was 93% and specificity was 100% of ICHD-3 criteria for idiopathic intracranial hypertension-related headache validated in idiopathic intracranial hypertension (n = 140) and patients in whom idiopathic intracranial hypertension was suspected but disproven (n = 103). The phenotype of new/worsened headaches related to idiopathic intracranial hypertension suspicion was equally migraine-like (p = 0.76) and tension-type-like (p = 0.08). Lumbar puncture opening pressure was higher (p < 0.0001) and pulsatile tinnitus more frequent (p < 0.0001) in idiopathic intracranial hypertension patients, but neither improved the applicability of the headache criteria, nor did papilledema. Conclusion: Headache phenotype is not distinct in idiopathic intracranial hypertension. ICHD-3 criteria for idiopathic intracranial hypertension headache are sensitive and specific, but simplicity can be improved without compromising accuracy. We propose that a new or worsened headache temporally related to active idiopathic intracranial hypertension is a sufficient criterion for idiopathic intracranial hypertension headache regardless of headache phenotype or accompanying symptoms, and that elements of idiopathic intracranial hypertension diagnostics (papilledema and opening pressure) be segregated from headache criteria. Trial Registration: ClinicalTrials.gov Identifier: NCT04032379

KW - headache classification

KW - Idiopathic intracranial hypertension

KW - International Classification of Headache Disorders

KW - intracranial pressure

KW - migraine

U2 - 10.1177/03331024241248210

DO - 10.1177/03331024241248210

M3 - Journal article

C2 - 38663903

AN - SCOPUS:85191466859

VL - 44

JO - Cephalalgia

JF - Cephalalgia

SN - 0800-1952

IS - 4

ER -

ID: 391211066